Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study

Journal of Research in Medical Sciences

Volumn 17, Issue 3, 2012, Pages 22-27

  Foroughipour, Mohsen ^a   Behdani, Fatemeh ^b   Hebrani, Paria ^b   Marvast, Majid Nabizadeh ^b   Esmatinia, Fereshte ^b   Akhavanrezayat, Amir ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Frequency; Multiple sclerosis; Obsessive compulsive disorder

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTONOMIC NERVE; CEREBELLUM; CRANIAL NERVE; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE; MULTIPLE SCLEROSIS; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PHYSICAL DISABILITY; SENSORY NERVE; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84859126342     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Zaudig M. Obsessive-compulsive disorder-clinical picture, diagnosis, and therapy. Z Psychosom Med Psychother 2011;57:3-50.
2. Assarian F, Biqam H, Asqarnejad A. An epidemiological study of obsessive-compulsive disorder among high school students and its relationship with religious attitudes. Arch Iran Med 2006;9:104-7.
3. Zaudig M. Heterogeneity and comorbidity of obsessivecompulsive disorder. Nervenarzt 2011;82:290, 292, 294-6.
4. Shabani A, Alizadeh A. The specific pattern of obsessive-compulsive symptoms in patients with bipolar disorder. JRMS 2008;13:48-54.
5. Schirmbeck F, Esslinger C, Rausch F, Englisch S, Meyer-Lindenberg A, Zink M. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011 Nov;41(11):2361-73
6. Yang XW, Lu XH. Molecular and cellular basis of obsessivecompulsive disorder-like behaviors: Emerging view from mouse models. Curr Opin Neurol 2011;24:114-8.
7. Kalatzis I, Piliouras N, Glotsos D, Ventouras E, Papageorgiou C, Rabavilas A, et al. Identifying Differences in the P600 Component of ERP-Signals between OCD Patients and Controls Employing a PNN-based Majority Vote Classification Scheme. Conf Proc IEEE Eng Med Biol Soc 2005;4:3994-7.
8. Zitterl W, Wimberger D, Demal U, Hofer E, Lenz G. Nuclear magnetic resonance tomography findings in obsessive-compulsive disorder. Nervenarzt 1994;65:619-22.
9. Gohle D, Juckel G, Mavrogiorgou P, Pogarell O, Mulert C, Rujescu D, Electrophysiological evidence for cortical abnormalities in obsessive-compulsive disorder-a replication study using auditory event-related P300 subcomponents. J Psychiatr Res 2008;42:297-303.
10. Kathmann N, Rupertseder C, Hauke W, Zaudig M. Implicit sequence learning in obsessive-compulsive disorder: Further support for the fronto-striatal dysfunction model. Biol Psychiatry 2005;58:239-44.
11. Shimizu E. The paradigm of abnormal sensory gating in fear extinction as pathophysiology in obsessive-compulsive disorder. Seishin Shinkeigaku Zasshi 2011;113:54-9.
12. Stüve O, Oksenberg J. Multiple Sclerosis Overview. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2006.
13. Marrie RA, Yu N, Blanchard J, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010;74:465-71.
14. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: A demographic study of 8,000 patients and changes over time. Eur Neurol 2010;64:331-6.
15. Comabella M, Khoury SJ. Immunopathogenesis of multiple sclerosis. Clin Immunol 2012;142:2-8.
16. Owens GP, Gilden D, Burgoon MP, Yu X, Bennett JL. Viruses and multiple sclerosis. Neuroscientist 2011;17:659-76.
17. Ramagopalan SV, Handel AE, Giovannoni G, Rutherford Siegel S, Ebers GC, Chaplin G. Relationship of UV exposure to prevalence of multiple sclerosis in England. Neurology 2011;76:1410-4.
18. Mitsonis CI, Potagas C, Zervas I, Sfagos K. The effects of stressful life events on the course of multiple sclerosis: a review. Int J Neurosci 2009;119:315-35.
19. Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: Definition, evolution, and clinical correlations. Acta Neurol Scand 2010;122:1-8.
20. Alajbegovic A, Loga N, Tiro N, Alajbegovic S, Todorovic L, Jasminika-Djelilovic. Depression in multiple sclerosis patients. Med Arh 2011;65:115-8.
21. Iacovides A, Andreoulakis E. Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: A review. Curr Opin Psychiatry 2011;24:336-40.
22. da Silva AM, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, et al. Depression and anxiety in a Portuguese MS population: Associations with physical disability and severity of disease. J Neurol Sci 2011;306:66-70.
23. Wilkening A, Haltenhof H. Mental disorders associated with multiple sclerosis. Dtsch Med Wochenschr 2006;131:154-8.
24. Ceschin L, Giannunzio V, Favaro A, Santonastaso P. Pica in an eating disordered woman with multiple sclerosis: impulse dyscontrol, compulsive symptom or self-medication attempt?. Eat Weight Disord 2010;15:e116-8.
25. George MS, Kellner CH, Fossey MD. Obsessive-compulsive symptoms in a patient with multiple sclerosis. J Nerv Ment Dis 1989;177:304-5.
26. Miguel EC, Stein MC, Rauch SL, O'Sullivan RL, Stern TA, Jenike MA. Obsessive-compulsive disorder in patients with multiple sclerosis. J Neuropsychiatry Clin Neurosci 1995;7:507-10.
27. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007;13:67-72.
28. Fontenelle LF, Harrison BJ, Yücel M, Pujol J, Fujiwara H, Pantelis C. Is there evidence of brain white-matter abnormalities in obsessive-compulsive disorder?: A narrative review. Top Magn Reson Imaging 2009;20:291-8.
29. Douzenis A, Michalopoulou PG, Voumvourakis C, Typaldou M, Michopoulos I, Lykouras L. Obsessive-compulsive disorder associated with parietal white matter multiple sclerosis plaques. World J Biol Psychiatry 2009;10:956-60.
30. Hoekstra PJ, Minderaa RB. Tic disorders and obsessive-compulsive disorder: Is autoimmunity involved?. Int Rev Psychiatry 2005;17:497-502.
31. Maina G, Albert U, Bogetto F, Borghese C, Berro AC, Mutani R, et al. Anti-brain antibodies in adult patients with obsessive-compulsive disorder. J Affect Disord 2009;116:192-200.
32. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
33. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-52.
34. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-11.
35. Greenberg DA, Aminoff MJ, Simon RP. Clinical neurology. 5th ed. New York: McGraw-Hill; 2002. p. 167-70.
36. Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008;15:239-45.
37. Feinstein A, O'Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999;5:323-6.
38. Exton MS, Baase J, Pithan V, Goebel MU, Limmroth V, Schedlowski M. Neuropsychological performance and mood states following acute interferon-beta-1b administration in healthy males. Neuropsychobiology 2002;45:199-204.
39. Weiss AP, Jenike MA. Late-Onset Obsessive-Compulsive Disorder: A case series. J Neuropsychiatry Clin Neurosci 2000;12:265-8.
40. Cilliçilli AS, Telcioglu M, Aşkin R, Kaya N, Bodur S, Kucur R. Twelve-month prevalence of obsessive-compulsive disorder in Konya, Turkey. Compr Psychiatry 2004;45:367-74.